J Med Cases
Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website http://www.journalmc.org

Case Report

Volume 5, Number 5, May 2014, pages 312-314


Successful Treatment of Life-Threatening Metabolic Alkalosis Due to Pyloric Stenosis: A Rare Case

Siva Parchaa, d, Purnima Tripathyb, Nikolay Azarova, Elaine De Prangc, Yasir Ahmeda

aDepartment of Internal Medicine, Texas Tech University of Health Science Center, Odessa, Texas, USA
bDepartment of Internal Medicine, Cleveland Clinic, Ohio, USA
cMedical Center Hospital, Odessa, Texas, USA
dCorresponding author: Siva Parcha, Department of Internal Medicine, Texas Tech University Health Science Center Odessa, Texas, USA

Manuscript accepted for publication December 9, 2013
Short title: Treatment of Metabolic Alkalosis
doi: https://doi.org/10.14740/jmc1623w

Abstract▴Top 

Alkalemia is defined as blood pH > 7.40 and if severe alkalemia pH > 7.60. Metabolic alkalosis is one of the common in-hospital acid-base disorders. Gastric outlet obstruction secondary to pyloric stenosis has been reported most frequent causes of severe metabolic alkalosis resulting from volume and hydrogen ion loss. Mortality is directly related to the severity of the acid base disturbances. As serum pH exceeds 7.60, the mortality also increases and can reach up to 80%. The current case is of a 41-year-old male with history of peptic ulcer disease presented with muscle cramps and confusion, and found to have severe metabolic alkalosis with an arterial pH of 7.91 mm Hg. He had superimposed acute kidney injury and severe hypokalemia which was successfully treated with aggressive volume repletion, hydrochloric acid infusion and surgery for pyloric stenosis. This is the severe reported life compatible level of metabolic alkalosis (pH: 7.91) to best our knowledge.

Keywords: Metabolic alkalosis; Acid-base disorders; Peptic ulcer disease; Acute pyloric stenosis

Introduction▴Top 

Metabolic alkalosis is one of the common acid-base disorders seen in hospital especially in intensive care units. Severe metabolic alkalemia is a rare but fatal condition, which is defined as pH > 7.60, and usually requires serum HCO3- more than 40 mmol/L. According to investigators, viable blood pH range is 6.80-7.80. It could be a life-threatening condition if prompt diagnosis and timely management is not provided. Here we present a case of severe metabolic alkalosis secondary to acute pyloric stenosis, probably highest ever reported life compatible level that was successfully treated with rapid correction of alkalemia with intravenous fluids and hydrochloric acid.

We see this range of severe metabolic alkalosis seldom and hence managing such critical cases is a challenge to the physicians.

Case Report▴Top 

A 41 years old male with history of peptic ulcer disease (PUD) presented with progressive dizziness associated with two episodes of syncope, paraesthesisas and confusion over a period of 3 days. Symptoms were preceded by severe nausea and intractable vomiting for 3 months. Patient endorsed 10 - 15 lb weight loss during this period. He was diagnosed with PUD 6 months ago, but it was non-compliant with prescribed proton pump inhibitor (PPI).

Examination revealed extremely dehydrated, disoriented, thin frail man in moderate distress with heart rate: 94/min, blood pressure: 127/81 mm Hg, respiratory rate: 24/min and temperature: 98 °F. Abdominal examination revealed hyperactive bowel sounds with mild distension and rest of systemic examinations was unremarkable.

Labs on admission suggested severe metabolic alkalosis with pH of 7.91 mm Hg, HCO3-: 62.8 mmol/L, pCO2: 31.2 mm Hg.

Electrocardiogram showed normal sinus rhythm, ventricular rate of 83/min and significantly prolonged corrected QT (QTc) interval of 650 ms. Urine electrolytes: random urine sodium 66 mmol/L, random urine chloride < 20 mmol/L. Given extreme dehydration and severe alkalosis he was admitted to ICU.

Patient received 12 L normal saline, potassium replacement, 500 mg acetazolamide followed by 8.3 mL of 37% hydrochloric acid diluted in 1 L of normal saline given over 4 h via central venous line. We attempted rapid correction with hydrochloric acid infusion in view of severity of condition and patient recovered without any complication. Alkalemia was resolved in 8 h (Table 1). Computed tomography (CT) of abdomen following stabilization revealed marked gastric distention with sub mucosal edema likely causing acute pyloric stenosis. Patient underwent endoscopic evaluation which confirmed severe pyloric stenosis. He subsequently underwent vagotomy, antrectomy and placement of jejunal feeding tube. Tube feedings was initiated and he had a complete recovery in acid-base balance, electrolytes (Table 2) and QTc on the EKG by day 2. At 4 weeks follow-up, he was symptom free and was successfully transitioned to oral nutrition after discontinuation of jejunal tube feeds.

Table 1.
Click to view
Table 1. Trends of the Arterial Blood Gases
 

Table 2.
Click to view
Table 2. Trends of the Electrolyte
 
Discussion▴Top 

Primary metabolic alkalosis is characterized as an acid-base disturbance associated with an elevated serum bicarbonate level (HCO3) and accompanied by an elevation in extracellular pH > 7.40 mm Hg. Significant alkalosis is usually associated with alveolar hypoventilation as a compensatory mechanism to increase pCO2. This compensatory changes is fairly linear and is predicted by the equation PaCO2 = 0.7 (HCO3) + 20. Severe alkalemia is defined as pH > 7.60 mm Hg [1]. Hospitalized patients are particularly at risk for metabolic acidosis due to vomiting, frequent use of naso-gastric tube, and so on [2]. Mortality from alkalosis is close to 50% at pH greater than 7.60 and reached 80% when pH is more than 7.65 mm Hg, hence, prompt therapy is prudent.

Metabolic alkalosis with pH 7.87 as highest ever documented previously in a case report [3], but here we are presenting a patient with severe metabolic alkalosis with pH 7.91 which is probably highest ever reported to the best of our knowledge.

Metabolic alkalosis is classified as either saline responsive or saline non-responsive. Most common causes of saline responsive metabolic alkalosis are extracellular volume depletion, high doses of antacids, gastrointestinal fluid losses, diuretics, and so on. Mineralocorticoid excess is the most common cause of a saline nonresponsive state. These both can be easily distinguished by performing a spot urinary chloride level which is usually < 10 mEq/L in saline responsive and > 20 mEq/L in saline non-responsive metabolic alkalosis [4]. In healthy patients, loss of gastric secretions usually does not cause metabolic alkalosis until unless there is concomitant volume depletion and renal dysfunction [5]. Gastric outlet obstruction secondary to pyloric stenosis is reported as a common cause of severe metabolic alkalosis especially in children, but very rare in adults.

Clinical manifestations of metabolic alkalosis include apathy, confusion, cardiac arrhythmias, neuromuscular irritability, seizures and compensatory hypoventilation.

Treatment should focus on identifying the source, aggressive volume replacement and electrolyte correction and rescue therapy with acetazolamide. In refractory cases intravenous hydrochloric acid infusion via a large central vein can be given [1]. Hemodialysis with a high-chloride and low acetate dialysate has been reported but data is very limited in adult patient and only few anecdotal cases reported use of in pediatric population [6].

Our patient had neuromuscular manifestations including apathy, confusion and severe muscle cramps. Urine chloride was < 20 mEq/L favoring saline responsive metabolic alkalosis from intractable vomiting secondary to acute pyloric stenosis. His alkalemia was resolved with aggressive hydration, acetazolamide 500 mg intravenously and 860 mEq hydrochloric acid infusion through central vein over 6 h. Later he underwent pyloric canal excision and dilatation without any complication.

Inadequately treated or advanced peptic ulcer diseases in adult’s poses a risk of pyloric stenosis which can present with life-threatening metabolic. Timely intervention can prevent progression to morbid severe metabolic alkalosis and reduce overall mortality [7]. Even though it is recommended that in chronic metabolic alkalosis pH should be corrected very slowly, in exceptional critical cases like ours rapid correction of pH can be attempted in view of high mortality. Further studies should be done to confirm this.

Disclosure

All authors declare there is no conflict of interest and no financial disclosures related to this case.


References▴Top 
  1. Korkmaz A, Yildirim E, Aras N, Ercan F. Hydrochloric acid for treating metabolic alkalosis. Jpn J Surg. 1989;19(5):519-523.
    doi pubmed
  2. Palmer BF, Alpern RJ. Metabolic alkalosis. J Am Soc Nephrol. 1997;8(9):1462-1469.
    pubmed
  3. Tugrul S, Telci L, Yildirim A, Yanar H, Cakar N. Case report of severe metabolic alkalosis: life-compatible new level. J Trauma. 2010;68(3):E61-63.
    doi pubmed
  4. Sherman RA, Eisinger RP. The use (and misuse) of urinary sodium and chloride measurements. JAMA. 1982;247(22):3121-3124.
    doi
  5. Tannen RL, Bleich HL, Schwartz WB. The renal response to acid loads in metabolic alkalosis; an assessment of the mechanisms regulating acid excretion. J Clin Invest. 1966;45(4):562-572.
    doi pubmed
  6. Banieghbal B. Rapid correction of metabolic alkalosis in hypertrophic pyloric stenosis with intravenous cimetidine: preliminary results. Pediatr Surg Int. 2009;25(3):269-271.
    doi pubmed
  7. Anderson LE, Henrich WL. Alkalemia-associated morbidity and mortality in medical and surgical patients. South Med J. 1987;80(6):729-733.
    doi


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Journal of Medical Cases is published by Elmer Press Inc.

 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.